Drug
Posaconazole
Posaconazole: highest development phase Approved, developed by Aurobindo, Merck. 2 trial records tracked on RxWires.
- Highest phase
- Approved
- Developer
- Aurobindo, Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| POSACONAZOLE | Approved | |
| Posaconazole NCT02180165 | Phase 3 | Aspergillosis |
Latest
No recent events.
Follow Posaconazole on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.